Shots:
- OsteoBoost receives the US FDA’s BDD to reduce the risk of osteoporosis. It uses vibration technology that delivers mechanical stimulation to the hips & spine at a precise, individually calibrated frequency, encouraging the body to reduce bone resorption & potentially create new bone
- An initial study showed that just one 30min treatment with OsteoBoost reduced bone loss activity in all participants, showing a decrease of 14%, a reduction on par with bisphosphonate drugs
- The NIH funded a $2M to study for determining the positive effects of OsteoBoost in a larger study with a broader population. The larger study is currently enrolling patients & is scheduled to be completed in early 2022
Click here to read full press release/ article | Ref: Bone Health Tech | Image: Linkedin
The post Bone Health’s OsteoBoost Vibration Belt Receives the US FDA’s Breakthrough Device Designation for Osteoporosis first appeared on PharmaShots.
